However, the approach taken in the PCB document, which is called the time frame for the application of the new guidelines and guidance documents in the approval of the active substance or in the CA-July12-Doc.6.2d (products) document, should be followed for tab entries requiring new data. The deadline is six months (active substance) or two years (products) before the date of submission of a first application and three and a half years before the expiry of the current application in the event of an extension, unless scientific progress shows that the invocation of old guidelines is of concern. The OPI part also provides general information on laws, information requirements and assessments. In addition, new elements (such as .B. Biocidal product families and comparative evaluation) with regard to the technical and scientific assessment described in the BPR, which does not relate to a specific aspect, such as physics, efficacy, human toxicology and the environment, described in separate paragraphs. New elements (BPRs) relating to technical and scientific assessment that do not relate to a specific aspect, such as physical chemistry, efficacy, human toxicology and the environment, are described below (e.g. BPF, SoC, etc.). Relevant CA documents by aspect are presented for that specific aspect. TAB procedure does not require the formal approval of the Biocidal Products Committee or the GA, as the document documents the agreements concluded in the GPs and included in its protocol. It is a living document that will be updated over time with new additions.
Core members shall be appointed for a renewable term of three years and each Member State may appoint up to two core members for each working group. 5. New elements of scientific assessment described in the Regulation and relevant for two or all aspects The following standing working groups have been established by the BPC: In addition to the standing working groups, four ad hoc working groups support the BPC and its permanent working groups: applicants may participate in the discussions of the BPC working group. . . .